Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...

Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...

Pancreatic cancer is the 12th most common cancer worldwide. In 2022, there were 510,992 new cases of pancreatic cancer, with ...

New blood tests like CancerGuard and Gallery claim to detect microscopic cancer markers in the bloodstream and screen for more than 50 types of cancer before symptoms develop. Doctors say the tests, ...

According to non-profit organization, Firefighter Cancer Support Network, cancer is the most dangerous threat to firefighters' health and safety.

Firefighters in Allentown, Pennsylvania, are getting a chance to take a blood test that can spot early signs of cancer. The ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

Liver disease is a growing health problem around the world, yet many people who develop it do not know they are sick until the disease has already become serious. Conditions such as liver fibrosis and ...

PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...

A controlled Norwegian case-control study examined circulating biomarkers of inflammation and neuronal injury in people with long COVID about 69 weeks after infection. The researchers found no ...

Testicular cancer is one of the most common cancers affecting young men, especially those between the ages of 20 and 40.

For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk ...